06:47

Fatal to Fearless: How Kathy Giusti and the MMRF changed the entire disease-fighting system

10:06

MMRF Road to Victories (R2V) Columbia River Gorge 2023 Full Feature Documentary

12:24

MMRF Moving Mountains for Multiple Myeloma (MM4MM) Alaska 2023 Full Feature Documentary

06:35

High-Risk Disease | High Impact Topic (HIT)

01:02:19

Myeloma Matters Podcast | Caregivers

13:44

Optimizing Your Outcome With MMRF Founder Kathy Giusti and Chief Mission Officer Anne Quinn Young

02:15

Driving Impact in 2024

01:07:21

Myeloma Matters Podcast | Maintenance Therapy

04:26

Research Program Updates | Myeloma Accelerator Challenge (MAC) Grants

05:17

CAR T-Cell Therapies | High Impact Topic (HIT)

02:47

Research Program Updates | MMRF Virtual Lab

05:05

A Health Equity Conversation with Anne Quinn Young and Dr. Monique Hartley-Brown

01:14

MMRF 25 Voices - Dr. David Avigan

01:08:21

Myeloma Matters Podcast | Relapsed/Refractory Multiple Myeloma

03:20

Research Program Updates | Immune Atlas

01:28

MMRF 25 Voices - Dr. Ken Anderson

04:09

MMRF Patient Stories: Geoff

03:48

MMRF Patient Stories: Gail

03:53

MMRF Patient Stories: Martha

02:00

MMRF 25 Voices - George Mulligan

01:21:26

Myeloma Matters Podcast | Newly Diagnosed Multiple Myeloma

00:56

MMRF 25 Voices - Dr. Saad Usmani

01:57

MMRF 25 Voices - Anne Quinn Young

01:24

MMRF 25 Voices - Dr. Faith Davies

04:52

Maintenance Therapy | High Impact Topic (HIT)

06:09

Bispecific Antibodies | High Impact Topic (HIT)

01:22

MMRF 25 Voices - Dr. Ajai Chari

01:23

MMRF 25 Voices - Dr. Hearn Jay Cho

01:11

MMRF 25 Voices - Dr. Suzanne Lentzsch

01:16

MMRF 25 Voices - Michael Andreini

01:01:23

FAQs on Clinical Studies

30:24

FAQs on BMCA-Targeted Bispecific Antibodies in Multiple Myeloma

01:18:42

Myeloma Matters Podcast | ASCT

57:04

Myeloma Matters Podcast | Clinical Studies

00:31

Black Men Deserve

01:05:48

Myeloma Matters Podcast | Targeted Immunotherapy

45:12

Myeloma Matters Podcast | Bone Health

01:02:47

Facebook Live 5/24/22: FAQs on Multiple Myeloma Diagnosis and Prognosis

21:41

Oncology Nursing Society Fireside Chat, Part 2 | CAR T-cell Therapy

26:29

Oncology Nursing Society Fireside Chat, Part 1 | Physical burden, treatment costs, and other issues

49:36

Multiple Myeloma Precursor Conditions | Overview | Therapeutic Intervention

51:36

Relapsed Refractory Multiple Myeloma | Current Treatment Options | Options on the Horizon

01:10:32

Newly Diagnosed Multiple Myeloma | Diagnosis, Initial Treatment | ASCT, Maintenance Therapy, Goals

44:26

Caregivers: An Essential Part of the Myeloma Care Team

57:11

Facebook Live 4/14/22: FAQs on Multiple Myeloma Following Relapse After 3 or More Lines of Therapy

03:33

Answering Your Questions About CARVYKTI™

03:02:50

MMRF Patient Summit 03.19.2022

02:57

1/19/2022 Covid-19 Update

01:05:23

Facebook Live 10/25/21: FAQs on Multiple Myeloma Precursor Conditions in the Black Community

32:40

International Myeloma Workshop 2021 | Daily Update, Part 3 | Newly Diagnosed + Relapsed/Refractory

28:19

International Myeloma Workshop 2021 | Daily Update, Part 2 | CAR-T Cell Therapy + Smoldering MM

35:56

International Myeloma Workshop 2021 | Daily Update, Part 1 | Newly Diagnosed + MRD

04:55

Genomics | High Impact Topic (HIT)

09:20

Learn Your Labs | High Impact Topic (HIT)

05:17

Immunotherapy | High Impact Topic (HIT)

04:44

Minimal Residual Disease (MRD) | High Impact Topic (HIT)

05:05

MMRF's The Right Track Program | High Impact Topic (HIT)

04:37

Multiple Myeloma Precursor Conditions | High Impact Topic (HIT)

04:29

Clinical Trials | High Impact Topic (HIT)

04:01

Autologous Hematopoietic Stem Cell Transplantation (ASCT) | High Impact Topic (HIT)